Decheng-Capital

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-08
Total Holdings
27
Total Value
356489453
Accession Number
0001104659-25-045686
Form Type
13F-HR
Manager Name
Decheng-Capital
Data Enrichment
89% identified
24 identified3 unidentified

Holdings

27 positions • $356.5M total value
Manager:
Search and click to pin securities to the top
Page 2 of 2
Equillium, Inc.
Shares:4.4M
Value:$1.7M
% of Portfolio:0.5% ($1.7M/$356.5M)
4D Molecular Therapeutics, Inc.
Shares:335.5K
Value:$1.1M
% of Portfolio:0.3% ($1.1M/$356.5M)
ILLUMINA, INC.
Shares:11.7K
Value:$932.2K
% of Portfolio:0.3% ($932.2K/$356.5M)
Pyxis Oncology, Inc.
Shares:326.8K
Value:$320.2K
% of Portfolio:0.1% ($320.2K/$356.5M)
GRAIL, Inc.
Shares:9.7K
Value:$247.3K
% of Portfolio:0.1% ($247.3K/$356.5M)
Vera Therapeutics, Inc.
Shares:4.5K
Value:$108.0K
% of Portfolio:0.0% ($108.0K/$356.5M)
67080N119
Shares:646.1K
Value:$44.0K
% of Portfolio:0.0% ($44.0K/$356.5M)